InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,193.72
(
0.25%
)
US TECH 100
17,669.20
(
0.34%
)
Dow Jones
38,877.26
(
0.06%
)
Brent Oil
83.40
(
-0.10%
)
Bitcoin
63,548.18
(
0.60%
)
Post# of 402736
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BonelessCat

Send PM Follow Ignore
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

BonelessCat

Re: alwaysdreaming post# 63922

Thursday, 07/24/2014 10:44:13 PM

Thursday, July 24, 2014 10:44:13 PM

Post# of 402736
The "another one of those drugs" phrasing was aimed at those who contend that preclinical outcomes are poor indicators for clinical results. Among many other clinical drugs I've examined, I indeed had Kevetrin in mind.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!